MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/iju.70462

Медицинская библиотека · International journal of urology : official journal of the Japanese Urological Association · 2026

Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic Therapy.

Akagi Naoki, Nagoshi Akihiko, Kubota Masashi, Hagimoto Hiroki, Hattori Yuto, Makita Noriyuki, Suzuki Ryosuke, Suzuki Issei, Akahane Mizuho, Abe Yohei, Fukunaga Arinobu, Tohi Yoichiro, Kono Yuka, Matsumoto Keiyu, Matsuoka Takashi, Tsutsumi Naohumi, Utsunomiya Noriaki, Shibasaki Noboru, Kawakita Mutsushi, Yamasaki Toshinari

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

To evaluate the safety of transrectal ultrasound (TRUS)-guided prostate biopsy performed without interruption of antithrombotic therapy.

METHODS

In this single-center retrospective study, we analyzed 2394 consecutive patients who underwent TRUS-guided prostate biopsy under sacral (caudal) anesthesia between July 2011 and March 2023. Patients were classified according to antithrombotic status at biopsy: no antithrombotic therapy, antiplatelet therapy, or anticoagulant therapy. Hemorrhagic complications were graded using the Clavien-Dindo classification. The primary endpoint was any Clavien-Dindo grade II or higher hemorrhagic complication; grade II and grade III events were also examined. Multivariable logistic regression analyses were performed with antithrombotic status as the main explanatory variable and age and platelet count as covariates.

RESULTS

Overall, 29 patients (1.2%) developed Clavien-Dindo grade II or higher hemorrhagic complications: 1.1% in the no antithrombotic group, 1.5% in the antiplatelet group, and 2.5% in the anticoagulant group. Neither antiplatelet nor anticoagulant therapy was associated with a significant increase in hemorrhagic complications compared with no antithrombotic therapy. No thromboembolic events were observed.

CONCLUSIONS

TRUS-guided prostate biopsy under sacral anesthesia appeared feasible without discontinuation of antithrombotic therapy and was not associated with a clear excess of clinically significant hemorrhagic complications. In selected patients, particularly those at high thromboembolic risk, continuing antithrombotic therapy may be a reasonable option, although a modest increase in bleeding risk cannot be definitively excluded.

Для цитирования: Akagi Naoki, Nagoshi Akihiko, Kubota Masashi, Hagimoto Hiroki, Hattori Yuto, Makita Noriyuki, Suzuki Ryosuke, Suzuki Issei, Akahane Mizuho, Abe Yohei, Fukunaga Arinobu, Tohi Yoichiro, Kono Yuka, Matsumoto Keiyu, Matsuoka Takashi, Tsutsumi Naohumi, Utsunomiya Noriaki, Shibasaki Noboru, Kawakita Mutsushi, Yamasaki Toshinari. Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic Therapy.. International journal of urology : official journal of the Japanese Urological Association. 2026. DOI: 10.1111/iju.70462.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.